Free Trial

Eurofins Scient (OTCMKTS:ERFSF) Shares Gap Down - What's Next?

Eurofins Scient logo with Medical background

Key Points

  • Eurofins Scientific's stock price gapped down from $79.13 to $76.15 before market opening, reflecting a decrease of 1.1%.
  • HSBC Global Research downgraded Eurofins Scientific from a "strong-buy" rating to a "hold" rating, while Citigroup maintained a "neutral" rating.
  • The company has a debt-to-equity ratio of 0.77, indicating a healthy balance of debt in relation to its equity.
  • MarketBeat previews top five stocks to own in October.

Eurofins Scient (OTCMKTS:ERFSF - Get Free Report) shares gapped down prior to trading on Wednesday . The stock had previously closed at $79.13, but opened at $76.15. Eurofins Scient shares last traded at $76.15, with a volume of 80 shares trading hands.

Analysts Set New Price Targets

Several research firms have recently weighed in on ERFSF. Citigroup reissued a "neutral" rating on shares of Eurofins Scient in a research report on Friday, July 25th. Hsbc Global Res lowered Eurofins Scient from a "strong-buy" rating to a "hold" rating in a research note on Friday, April 25th. Finally, HSBC lowered Eurofins Scient to a "hold" rating in a research note on Friday, April 25th. Five analysts have rated the stock with a hold rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold".

Get Our Latest Analysis on ERFSF

Eurofins Scient Price Performance

The business has a 50 day moving average of $73.59 and a 200 day moving average of $63.20. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.26 and a quick ratio of 1.19.

Eurofins Scient Company Profile

(Get Free Report)

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products.

Further Reading

Should You Invest $1,000 in Eurofins Scient Right Now?

Before you consider Eurofins Scient, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eurofins Scient wasn't on the list.

While Eurofins Scient currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.